Drug Discovery Informatics industry associations and research organizations
Product managers, Drug Discovery Informatics industry administrator, C-level executives of the industries
Market Research and consulting firms
GMM Market Research Report Contains Answers Following Questions?
What are market dynamics of Drug Discovery Informatics market? What are challenges and opportunities?
Who are the global key players in this Drug Discovery Informatics market? Whats their company profile, their product information, contact information?
What was global market status of Drug Discovery Informatics market? What was capacity, production value, cost and profit of Drug Discovery Informatics market?
What is current market status of Drug Discovery Informatics market growth? Whats market analysis of Drug Discovery Informatics market by taking applications and types in consideration?
expected to reach USD 5.63 billion by 2028 registering a
CAGR of 11.3% over the forecast period, according to a new report by Grand View Research, Inc. Use of drug discovery software for gaining market intelligence owing to several advantages, such as rapid drug design & synthesis, efficient tracking of disease evolution, and data integrity management, has increased significantly among the researchers in the recent years, driving the industry growth.
Key suggestions from the report:
The discovery workflow segment accounted for the largest share of 59.19% in 2020 owing to the increased focus of pharmaceutical companies on the development of novel drug candidates
The development workflow segment is expected to register the fastest CAGR from 2021 to 2028 owing to a rise in the number of drug candidates in the clinical development phase
Top Key Players Profiled in this report are:
IBM, Infosys, Thermo Fisher Scientific, Perkinelmer, Schrödinger, Dassault Systèmes, Charles River Laboratories, Selvita, Certara, GVK Biosciences, Collaborative Drug Discovery, Openeye Scientific Software, IO Informatics, Novo Informatics.
Various factors are responsible for the market’s growth trajectory, which are studied at length in the report. In addition, the report lists down the restraints that are posing threat to the global Drug Discovery Informatics market. It also gauges the bargaining power of suppliers and buyers, threat from new entrants and product substitute, and the degree of competition prevailing in the market. The influence of the latest government guidelines is also analyzed in detail in the report. It studies the Drug Discovery Informatics market’s trajectory between forecast periods.
PharmiWeb.com is Europe s leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. follow us Version: 2021.4.7.1
You are leaving PharmiWeb.com
Disclaimer: You are now leaving PharmiWeb.com website and are going to a website that is not operated by us. We are not responsible for the content or availability of linked sites.
This study mainly helps understand which market segments or Region or Country they should focus on coming years to channelize their efforts and investments to maximize growth and profitability. The report presents the market competitive landscape and a consistent in-depth analysis of the major vendor/key players in the market. Moreover, it will also include the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product services of key players.
Region Included are: North America, Europe, Asia Pacific, Oceania, South America, Middle East & Africa
Strategic Points Covered in Table of Content of Drug Discovery Informatics Market: